Epizyme: 2Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Epizyme Inc. (EPZM) on Friday reported a loss of $48.5 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of 53 cents per share.
The results met Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was also for a loss of 53 cents per share.
The biopharmaceutical company posted revenue of $5.9 million in the period.
Epizyme shares have risen 98% since the beginning of the year. The stock has risen 23% in the last 12 months.